Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A single-nucleotide polymorphism of the Fcγ receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignancies.
Takami A, Espinoza JL, Onizuka M, Ishiyama K, Kawase T, Kanda Y, Sao H, Akiyama H, Miyamura K, Okamoto S, Inoue M, Ohtake S, Fukuda T, Morishima Y, Kodera Y, Nakao S; Japan Marrow Donor Program. Takami A, et al. Among authors: akiyama h. Bone Marrow Transplant. 2011 Feb;46(2):238-43. doi: 10.1038/bmt.2010.88. Epub 2010 Apr 19. Bone Marrow Transplant. 2011. PMID: 20400988
Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan Marrow Donor Program.
Inamoto Y, Miyamura K, Okamoto S, Akiyama H, Iida H, Eto T, Morishima Y, Kawa K, Kikuchi A, Nagatoshi Y, Tanaka J, Ashida T, Hirokawa M, Tsuchida M, Mori S. Inamoto Y, et al. Among authors: akiyama h. Bone Marrow Transplant. 2011 Sep;46(9):1192-202. doi: 10.1038/bmt.2010.281. Epub 2010 Nov 8. Bone Marrow Transplant. 2011. PMID: 21057551
A single nucleotide polymorphism of IL-17 gene in the recipient is associated with acute GVHD after HLA-matched unrelated BMT.
Espinoza JL, Takami A, Onizuka M, Kawase T, Sao H, Akiyama H, Miyamura K, Okamoto S, Inoue M, Ohtake S, Fukuda T, Morishima Y, Kodera Y, Nakao S; Japan Marrow Donor Program. Espinoza JL, et al. Among authors: akiyama h. Bone Marrow Transplant. 2011 Nov;46(11):1455-63. doi: 10.1038/bmt.2010.325. Epub 2011 Jan 10. Bone Marrow Transplant. 2011. PMID: 21217785
M-CSF attenuates severity of chronic GVHD after unrelated BMT.
Kimura F, Sato K, Akiyama H, Sao H, Okamoto S, Kobayashi N, Hara M, Kawa K, Motoyoshi K; Japan Marrow Donor Program. Kimura F, et al. Among authors: akiyama h. Bone Marrow Transplant. 2012 Mar;47(3):426-9. doi: 10.1038/bmt.2011.90. Epub 2011 Apr 18. Bone Marrow Transplant. 2012. PMID: 21499320
Secondary solid tumors after allogeneic hematopoietic SCT in Japan.
Yokota A, Ozawa S, Masanori T, Akiyama H, Ohshima K, Kanda Y, Takahashi S, Mori T, Nakaseko C, Onoda M, Kishi K, Doki N, Aotsuka N, Kanamori H, Maruta A, Sakamaki H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Yokota A, et al. Among authors: akiyama h. Bone Marrow Transplant. 2012 Jan;47(1):95-100. doi: 10.1038/bmt.2011.23. Epub 2011 Feb 28. Bone Marrow Transplant. 2012. PMID: 21358690
Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry.
Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, Taniguchi S, Miyamura K, Takahashi S, Eto T, Ogawa H, Kurokawa M, Tanaka J, Kawa K, Kato K, Suzuki R, Morishima Y, Sakamaki H, Fukuda T. Kurosawa S, et al. Among authors: akiyama h. Bone Marrow Transplant. 2013 Apr;48(4):529-36. doi: 10.1038/bmt.2012.172. Epub 2012 Sep 10. Bone Marrow Transplant. 2013. PMID: 22964595 Clinical Trial.
Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia.
Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, Taniguchi S, Miyamura K, Takahashi S, Eto T, Ogawa H, Kurokawa M, Tanaka J, Kawa K, Kato K, Suzuki R, Morishima Y, Sakamaki H, Fukuda T. Kurosawa S, et al. Among authors: akiyama h. Bone Marrow Transplant. 2013 Sep;48(9):1198-204. doi: 10.1038/bmt.2013.42. Epub 2013 Apr 8. Bone Marrow Transplant. 2013. PMID: 23562971
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia.
Mizuta S, Matsuo K, Yagasaki F, Yujiri T, Hatta Y, Kimura Y, Ueda Y, Kanamori H, Usui N, Akiyama H, Miyazaki Y, Ohtake S, Atsuta Y, Sakamaki H, Kawa K, Morishima Y, Ohnishi K, Naoe T, Ohno R. Mizuta S, et al. Among authors: akiyama h. Leukemia. 2011 Jan;25(1):41-7. doi: 10.1038/leu.2010.228. Epub 2010 Oct 14. Leukemia. 2011. PMID: 20944676
2,402 results